Ginsenoside Rg1, a Natural Lysosomal Enhancer, Alleviates Parkinson's Disease Pathology via Cathepsin D ‐Dependent Regulation of α‐Synuclein Homeostasis
Phytotherapy Research · 2026
DOI: 10.1002/ptr.70392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2026. Verfasst von Ya-Nan Fei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Ginsenosides, Cathepsin D, alpha-Synuclein, Lysosomes. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Major Science and Technology Projects in Yunnan Province, Cultivating Plan Program for the Leader in Science and Technology of Yunnan Province.
Abstract (Originalsprache)
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuron loss and α‐synuclein (α‐syn) aggregation, often linked to lysosomal dysfunction. Cathepsin D (CTSD), a lysosomal hydrolase essential for α‐syn clearance, becomes functionally impaired when its maturation is disrupted, exacerbating proteostatic stress. This study investigated whether ginsenoside Rg1(Rg1) restores CTSD maturation and lysosomal function to mitigate PD pathology. MPTP‐induced zebrafish and mouse PD models, as well as MPP+‐treated SH‐SY5Y cells, animals and cells were treated with Rg1 at different concentrations. Motor behavior, dopaminergic neuron survival, α‐syn clearance, CTSD maturation, lysosomal activity, endoplasmic reticulum (ER) stress, oxidative stress, autophagic flux, and apoptosis were systematically evaluated. Rg1 improved locomotor performance and preserved dopaminergic neurons, promoted α‐syn clearance, and enhanced CTSD maturation in lysosomes. These effects coincided with reduced ER and oxidative stress, normalized autophagic flux, and decreased apoptosis. Rg1 functions as a natural lysosomal enhancer, restoring lysosome‐ER homeostasis and counteracting multiple pathogenic pathways in PD. The findings reveal a CTSD‐dependent regulatory axis in α‐syn homeostasis and highlight Rg1 as a promising multi‐target therapeutic candidate for PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan, China.
- National-Local Joint Engineering Research Centre for Sanqi Resource Protection and Utilisation Technology, Kunming, Yunnan, China.
ORCID-Profile: Jun Sang, Tian-Rui Xu
Förderung
- National Natural Science Foundation of China
- Major Science and Technology Projects in Yunnan Province
- Cultivating Plan Program for the Leader in Science and Technology of Yunnan Province
Zitieren
APA
Fei, Y. N., Hao, M. Y., Liu, J. Q., Dong, Y. S., Zou, H. N., Guo, X. X., An, S., Sang, J., & Xu, T. R. (2026). Ginsenoside Rg1, a Natural Lysosomal Enhancer, Alleviates Parkinson's Disease Pathology via Cathepsin D ‐Dependent Regulation of α‐Synuclein Homeostasis. Phytotherapy Research. https://doi.org/10.1002/ptr.70392
Vancouver
Fei YN, Hao MY, Liu JQ, Dong YS, Zou HN, Guo XX, et al. Ginsenoside Rg1, a Natural Lysosomal Enhancer, Alleviates Parkinson's Disease Pathology via Cathepsin D ‐Dependent Regulation of α‐Synuclein Homeostasis. Phytotherapy Research. 2026. doi:10.1002/ptr.70392
BibTeX
@article{Fei2026,
author = {Fei, Ya-Nan and Hao, Ming-Yang and Liu, Jia-Qiang and Dong, Yin-Song and Zou, Hui-Ning and Guo, Xiao-Xi and An, Su and Sang, Jun and Xu, Tian-Rui},
title = {Ginsenoside Rg1, a Natural Lysosomal Enhancer, Alleviates Parkinson's Disease Pathology via Cathepsin D ‐Dependent Regulation of α‐Synuclein Homeostasis},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70392}
}
EUVIMED